Hepion Pharmaceuticals Inc (HEPA)
1.32
+0.08
(+6.45%)
USD |
NASDAQ |
May 17, 16:00
1.32
0.00 (0.00%)
Pre-Market: 20:00
Hepion Pharmaceuticals Total Liabilities (Quarterly): 10.81M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 10.81M |
| September 30, 2023 | 8.844M |
| June 30, 2023 | 10.13M |
| March 31, 2023 | 12.34M |
| December 31, 2022 | 10.39M |
| September 30, 2022 | 10.44M |
| June 30, 2022 | 16.25M |
| March 31, 2022 | 9.219M |
| December 31, 2021 | 10.56M |
| September 30, 2021 | 8.959M |
| June 30, 2021 | 9.032M |
| March 31, 2021 | 6.182M |
| December 31, 2020 | 8.125M |
| September 30, 2020 | 7.491M |
| June 30, 2020 | 5.792M |
| March 31, 2020 | 4.502M |
| December 31, 2019 | 4.995M |
| September 30, 2019 | 4.847M |
| June 30, 2019 | 5.310M |
| March 31, 2019 | 7.259M |
| December 31, 2018 | 6.214M |
| Date | Value |
|---|---|
| September 30, 2018 | 9.727M |
| June 30, 2018 | 8.727M |
| March 31, 2018 | 6.345M |
| September 30, 2017 | 9.128M |
| June 30, 2017 | 9.327M |
| March 31, 2017 | 12.15M |
| December 31, 2016 | 10.19M |
| September 30, 2016 | 11.81M |
| June 30, 2016 | 11.79M |
| March 31, 2016 | 5.454M |
| December 31, 2015 | 5.662M |
| September 30, 2015 | 4.215M |
| June 30, 2015 | 1.938M |
| March 31, 2015 | 1.616M |
| December 31, 2014 | 0.361M |
| September 30, 2014 | 0.4647M |
| June 30, 2014 | 4.934M |
| March 31, 2014 | 9.986M |
| December 31, 2013 | 0.4987M |
| September 30, 2013 | 0.3986M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
4.502M
Minimum
Mar 2020
16.25M
Maximum
Jun 2022
8.643M
Average
8.959M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| Ionis Pharmaceuticals Inc | 2.467B |
| Madrigal Pharmaceuticals Inc | 231.52M |
| Galectin Therapeutics Inc | 96.98M |
| Viking Therapeutics Inc | 33.63M |
| 89bio Inc | 66.78M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 18.09M |
| Shareholders Equity (Quarterly) | 7.281M |